WHO ICTRP trial
A study to describe the effectiveness of arrhythmia analysis software for…
NL-OMON54431 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON54431 |
|---|---|
| Public title | A study to describe the effectiveness of arrhythmia analysis software for screening of Sinus rhythm, Atrial Fibrillation and premature beats in light skin-and dark skin tone patients |
| Scientific title | A study to describe the effectiveness of arrhythmia analysis software for screening of Sinus rhythm, Atrial Fibrillation and premature beats in light skin-and dark skin tone patients - Huawei Afib study |
| Primary sponsor | Huawei Device Co., Ltd |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Countries | The Netherlands |
| Conditions | Cardiac arrhythmias;10007521;Cardiac arrhythmias |
| Interventions | ;Cardiac arrhythmias;Skin Tone;Smartwatch |
| Registration date | Jun 15, 2023 |
| Target size | 84 |
| Secondary IDs | NL78353.000.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: